Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options
 Abivax ABVX 6. mar 2026 94.00 -5.15   
 Accor SA AC 6. mar 2026 43.33 -2.41   
 Aeroports de Paris SA ADP 6. mar 2026 107.70 -1.19   
 Air Liquide AI 6. mar 2026 167.30 -1.76   
 Airbus SE AIR 6. mar 2026 175.50 -0.22   
 Alstom SA ALO 6. mar 2026 24.33 -3.76   
 Alten SA ATE 6. mar 2026 60.90 +1.16   
 Amundi AMUN 6. mar 2026 74.90 -0.93   
 ARCELORMITTAL MT 6. mar 2026 47.90 -2.86   
 Arkema SA AKE 6. mar 2026 52.75 -5.72   
 AXA CS 6. mar 2026 37.89 -0.42   
 Ayvens AYV 6. mar 2026 10.01 -0.20   
 Biomerieux BIM 6. mar 2026 95.40 +0.16   
 BNP Paribas SA BNP 6. mar 2026 86.35 -0.78   
 Bolloré BOL 6. mar 2026 4.47 -2.57   
 Bouygues SA EN 6. mar 2026 48.90 -1.19   
 Bureau Veritas SA BVI 6. mar 2026 28.80 -0.41   
 CAC 40 CAC 6. mar 2026 7 993.49 -0.65   
 Capgemini SE CAP 6. mar 2026 109.75 +0.09   
 Carrefour SA CA 6. mar 2026 15.22 -0.07   
 Cie de Saint-Gobain SGO 6. mar 2026 74.06 -2.45   
 Covivio COV 6. mar 2026 57.70 +0.09   
 Credit Agricole SA ACA 6. mar 2026 16.79 -1.26   
 Danone SA BN 6. mar 2026 70.20 +0.23   
 Dassault Aviation AM 6. mar 2026 333.80 +5.77   
 Dassault Systemes SE DSY 6. mar 2026 18.74 +0.46   
 Edenred SE EDEN 6. mar 2026 18.79 -2.44   
 Eiffage SA FGR 6. mar 2026 135.15 -1.71   
 Elis SA ELIS 6. mar 2026 24.66 -0.16   
 Engie SA ENGI 6. mar 2026 26.35 -0.64   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.